Mdm2 links genotoxic stress and metabolism to p53

被引:22
|
作者
Wang, Zhongfeng [1 ]
Li, Baojie [1 ]
机构
[1] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Ctr, Shanghai 200240, Peoples R China
关键词
mouse double minute 2 (Mdm2); p53; signal transduction; tumorigenesis;
D O I
10.1007/s13238-010-0140-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mouse double minute 2 (Mdm2) gene was isolated from a cDNA library derived from transformed mouse 3T3 cells, and was classified as an oncogene as it confers 3T3 and Rat2 cells tumorigenicity when overexpressed. It encodes a nucleocytoplasmic shuttling ubiquitin E3 ligase, with its main target being tumor suppressor p53, which is mutated in more than 50% of human primary tumors. Mdm2's oncogenic activity is mainly mediated by p53, which is activated by various stresses, especially genotoxic stress, via Atm (ataxia telangiectasia mutated) and Atr (Atm and Rad3-related). Activated p53 inhibits cell proliferation, induces apoptosis or senescence, and maintains genome integrity. Mdm2 is also a target gene of p53 transcription factor. Thus, Mdm2 and p53 form a feedback regulatory loop. External and internal cues, through multiple signaling pathways, can act on Mdm2 to regulate p53 levels and cell proliferation, death, and senescence. This review will focus on how Mdm2 is regulated under genotoxic stress, and by the Akt1-mTOR-S6K1 pathway that is activated by insulin, growth factors, amino acids, or energy status.
引用
收藏
页码:1063 / 1072
页数:10
相关论文
共 50 条
  • [31] Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma
    Segers, K
    Backhovens, H
    Kumar-Singh, S
    DeVoecht, J
    Ramael, M
    Van Broeckhoven, C
    VanMarck, E
    VIRCHOWS ARCHIV, 1995, 427 (04) : 431 - 436
  • [32] p53 AND MDM2 PROTEIN EXPRESSION IN ACTINIC CHEILITIS
    Andrade de Freitas, Maria da Conceicao
    Pedreira Ramalho, Luciana Maria
    Aquino Xavier, Flavia Calo
    Gomes Moreira, Andre Luis
    Almeida Reis, Silvia Regina
    JOURNAL OF APPLIED ORAL SCIENCE, 2008, 16 (06) : 414 - 419
  • [33] Mdm2 association with p53 targets its ubiquitination
    Serge Y Fuchs
    Victor Adler
    Thomas Buschmann
    Xiangwei Wu
    Ze'ev Ronai
    Oncogene, 1998, 17 : 2543 - 2547
  • [34] Modulation of the p53/MDM2 interplay by HAUSP inhibitors
    Tavana, Omid
    Gu, Wei
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2017, 9 (01) : 45 - 52
  • [35] Expression of mdm2 and p53 in epithelial neoplasms of the colorectum
    Hao, XP
    Günther, T
    Roessner, A
    Price, AB
    Talbot, IC
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (01): : 26 - 29
  • [36] p53 and MDM2 in the development and progression of bladder cancer
    SchmitzDrager, BJ
    Kushima, M
    Goebell, P
    Jax, TW
    Gerharz, CD
    Buttel, H
    Schulz, WA
    Ebert, T
    Ackermann, R
    EUROPEAN UROLOGY, 1997, 32 (04) : 487 - 493
  • [37] Alterations of the p53, Rb and MDM2 genes in osteosarcoma
    Miller, CW
    Aslo, A
    Won, A
    Tan, M
    Lampkin, B
    Koeffler, HP
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (09) : 559 - 565
  • [38] Targeting the p53–MDM2 interaction to treat cancer
    C Klein
    L T Vassilev
    British Journal of Cancer, 2004, 91 : 1415 - 1419
  • [39] Small molecule inhibitors of p53/MDM2 interaction
    Fotouhi, N
    Graves, B
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 159 - 165
  • [40] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9